Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate (Q28083338)

title

Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate (English)

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Torge Rempe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Günther Deuschl

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

8

Olav Jansen

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Arne Wrede

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Frank Leypoldt

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Wolfgang Brück

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Ortwin Adams

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Axel Rohr

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Christian Wüthrich

9

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Igor J Koralnik

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

1 reference

October 2015

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

78

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

501-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

14 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

The human polyomavirus, JCV, uses serotonin receptors to infect cells

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Persistence and pathogenesis of the neurotropic polyomavirus JC

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Dimethyl fumarate associated lymphopenia in clinical practice.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Idiopathic CD4 lymphocytopenia: clinical and immunologic characteristics and follow-up of 40 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JCV testing.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Progressive multifocal leukoencephalopathy: why gray and white matter

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Metabolic profile of PML lesions in patients with and without IRIS: an observational study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Determinants of survival in progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Asymptomatic reactivation of JC virus in patients treated with natalizumab

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Identification and characterization of mefloquine efficacy against JC virus in vitro

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Seizures and their outcome in progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-kappa B1, but not RelA in normal human dermal fibroblast cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Drug-induced lymphopenia: focus on CD4+ and CD8+ cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Finger pointing to JC virus: a tale of two indexes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926166

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

2 June 2018

1 reference

Dimethylfumarate is a potent inducer of apoptosis in human T cells

21 January 2018

1 reference

Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis

21 January 2018

1 reference

Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy

21 January 2018

1 reference

Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis.

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis

21 January 2018

1 reference

Diagnosis of central nervous system complications in HIV-infected patients

21 January 2018

1 reference

PML in a patient treated with fumaric acid

21 January 2018

1 reference

12 December 2020

PML in a patient treated with dimethyl fumarate from a compounding pharmacy

1 reference

12 December 2020

Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis

1 reference

12 December 2020

PML in a patient with lymphocytopenia treated with dimethyl fumarate

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies

1 reference

12 December 2020

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

12 December 2020

PML in a patient without severe lymphocytopenia receiving dimethyl fumarate

1 reference

12 December 2020

The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk

1 reference

12 December 2020

Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera

1 reference

12 December 2020

Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Identifiers

DOI

10.1002/ANA.24471

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150206%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

PubMed publication ID

26150206

2 references